Epigenetic Analysis of KSHV Latent and Lytic Genomes by Toth, Zsolt et al.
Epigenetic Analysis of KSHV Latent and Lytic Genomes
Zsolt Toth
1, Dennis T. Maglinte
2, Sun Hwa Lee
1, Hye-Ra Lee
1, Lai-Yee Wong
1, Kevin F. Brulois
1, Stacy
Lee
1, Jonathan D. Buckley
2,3, Peter W. Laird
2, Victor E. Marquez
4, Jae U. Jung
1*
1Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America,
2USC Epigenome Center, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America, 3Department of Preventive
Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America, 4Laboratory of Medicinal Chemistry, Center for
Cancer Research, NCI-Frederick, Frederick, Maryland, United States of America
Abstract
Epigenetic modifications of the herpesviral genome play a key role in the transcriptional control of latent and lytic genes
during a productive viral lifecycle. In this study, we describe for the first time a comprehensive genome-wide ChIP-on-Chip
analysis of the chromatin associated with the Kaposi’s sarcoma-associated herpesvirus (KSHV) genome during latency and
lytic reactivation. Depending on the gene expression class, different combinations of activating [acetylated H3 (AcH3) and
H3K4me3] and repressive [H3K9me3 and H3K27me3] histone modifications are associated with the viral latent genome,
which changes upon reactivation in a manner that is correlated with their expression. Specifically, both the activating marks
co-localize on the KSHV latent genome, as do the repressive marks. However, the activating and repressive histone
modifications are mutually exclusive of each other on the bulk of the latent KSHV genome. The genomic region encoding
the IE genes ORF50 and ORF48 possesses the features of a bivalent chromatin structure characterized by the concomitant
presence of the activating H3K4me3 and the repressive H3K27me3 marks during latency, which rapidly changes upon
reactivation with increasing AcH3 and H3K4me3 marks and decreasing H3K27me3. Furthermore, EZH2, the H3K27me3
histone methyltransferase of the Polycomb group proteins (PcG), colocalizes with the H3K27me3 mark on the entire KSHV
genome during latency, whereas RTA-mediated reactivation induces EZH2 dissociation from the genomic regions encoding
IE and E genes concurrent with decreasing H3K27me3 level and increasing IE/E lytic gene expression. Moreover, either the
inhibition of EZH2 expression by a small molecule inhibitor DZNep and RNAi knockdown, or the expression of H3K27me3-
specific histone demethylases apparently induced the KSHV lytic gene expression cascade. These data indicate that histone
modifications associated with the KSHV latent genome are involved in the regulation of latency and ultimately in the
control of the temporal and sequential expression of the lytic gene cascade. In addition, the PcG proteins play a critical role
in the control of KSHV latency by maintaining a reversible heterochromatin on the KSHV lytic genes. Thus, the regulation of
the spatial and temporal association of the PcG proteins with the KSHV genome may be crucial for propagating the KSHV
lifecycle.
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Introduction
Chromatin is a highly dynamic structure of nucleosomes that
are composed of DNA wrapped around the core histones (H2A,
H2B, H3 and H4). Over the past decade, several studies have
demonstrated that histones are subject to various posttranslation-
al modifications (acetylation, methylation, phosphorylation, and
ubiquitination), which are capable of modulating chromatin
structures to thereby influence gene expression [1]. Hyperacety-
lation of histones H3 and H4 occurs mainly on promoters and
correlates with gene activation, while hypoacetylation is charac-
teristic of repressed genes [2]. Histone methylation is associated
with either activation or repression of genes, depending on which
histone lysine residues are mono-, di- or trimethylated. Various
histone methylations are then recognized by specific chromodo-
main-containing proteins that can function as either transcription
factors or as part of large chromatin remodelling/modifying
complexes, which eventually determine the activity of target
genes [1].
Histone methylation status fluctuates in response to environ-
mental and developmental conditions. A number of enzymes that
add or remove methylation modifications have been discovered
[3,4]. In general, transcriptionally active genes are associated with
H3K4me3 and H3K36me3, whereas trimethylation of H3K9,
H3K27 and H4K20 occurs primarily on repressed genes.
H3K9me3 and H4K20me3 histone modifications are character-
istic of pericentric heterochromatin, which is considered to be
constitutive heterochromatin [5,6,7,8,9]. On the other hand,
H3K27me3 is the marker of highly dynamic and reversible
heterochromatin (facultative heterochromatin), and is character-
istic of genes that are subject to tissue specific or developmentally
regulated expression [10,11,12]. Genome-wide analysis of embry-
onic stem (ES) cells revealed that H3K27me3 preferentially
localizes on developmental genes, which are repressed in stem
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Interestingly, the promoter of large number of these developmen-
tal genes are also enriched in activating H3K4me3 suggesting that
these genes are silenced but poised for rapid activation in ES cells
[15]. Promoters enriched in both activating (H3K4me3) and
repressive (H3K27me3) histone marks, called bivalent promoters,
have been associated with rapidly inducible genes in T cells as well
[7].
H3K27me3 is deposited by the evolutionary conserved 600-kDa
Polycomb Repressive Complex 2 (PRC2), which consists of three
Polycomb group (PcG) proteins (EZH2, SUZ12, EED) and the
histone-binding proteins, RbAp48/46 [16]. The SET domain-
containing EZH2 is an H3K27me3 histone methyltransferase,
which can be found along entire genomic regions enriched with
H3K27me3 in mammalian cells [17]. H3K27me3 provides a
binding platform for PRC1, a larger Polycomb complex consisting
of more than 10 subunits. In Drosophila, PcG proteins are
recruited to their target genes via Polycomb response elements
(PRE) that can be found in promoters [18]. It is still unclear how
PcG proteins are recruited to their target genes in mammalian
cells, but non-coding RNAs and specific DNA sequences similar to
PREs have been implicated to be involved in this process.
[16,19,20]. Polycomb-mediated gene silencing has been shown to
be reversible with H3K27me3 demethylases such as JMJD3 and
UTX, which can be recruited to the repressed promoters by
transcription activators as has been shown, for instance, in the case
of the H3K4me3 methyltransferase complexes [21,22,23,24].
Viruses replicating in the nucleus are also under the influence of
the chromatin during different stages of their life cycles. Therefore,
viruses have evolved various mechanisms to utilize or neutralize
the impact of cellular chromatin factors, to ultimately control viral
replication and gene expression [25,26,27,28]. Herpesviruses have
a large DNA genome that persists as multicopy circular episomes
associated with histones in the nucleus. Herpesviral infection can
lead to two different life cycles: latency and lytic replication.
During latency, the viral episomes are assembled into nucleosomal
structures that resemble bulk cellular chromatin. Regulation of the
chromatin structure of the Herpes simplex virus type 1 (HSV-1)
genome has been implicated as the underlying cause of the switch
between latency and lytic replication as well as being involved in
the regulation of lytic gene expression [29,30].
A human tumour virus, called Kaposi’s sarcoma-associated
herpesvirus (KSHV) or human herpesvirus 8 (HHV8), has been
consistently identified in Kaposi’s sarcoma (KS) tumours, pleural
effusion lymphoma (PEL), and Multicentric Castleman disease
[31,32,33]. Several studies have indicated that DNA methylation
and histone acetylation can play a role in the regulation of KSHV
gene expression [34,35]. The immediate early KSHV gene
encoded by ORF50, called RTA (replication and transcription
activator), is the master regulatory factor and is sufficient to induce
the complete cycle of viral replication [36,37]. The RTA promoter
associates with histone deacetylases (HDACs) during latency
resulting in hypoacetylated histones [34]. Treatment of latently
infected KSHV positive cells with HDAC inhibitors, butyrate or
TSA, induces the hyperacetylation of viral chromatin concomi-
tantly with the recruitment of histone acetyltransferases, chromatin
remodelling proteins (Ini1/Snf5) and the TRAP/Mediator
coactivator complex to the RTA promoter, allowing RTA
expression to induce the complete viral gene expression cascade
[34,38].
To elucidate the characteristics of the KSHV epigenome, we
performed a high-resolution genome-wide analysis to map a set of
activating and repressive histone H3 modifications on the entire
KSHV genome during latency and reactivation. Based on their
genome-wide profiles, we found that the KSHV genes are
associated with a distinctive pattern of active and repressive
histone modifications during latency, which ultimately changes
upon reactivation. Importantly, the promoter regions of RTA and
several E genes are associated with both H3K4me3 and
H3K27me3 marks, suggesting that these promoters have a
bivalent chromatin structure that maintains their repression
during latency and is also poised for rapid activation upon
stimulation. We also found that while the EZH2 histone
methyltransferase is colocalized with H3K27me3 on the entire
KSHV latent genome, it rapidly dissociates from the RTA
promoter and other IE-E gene-rich genomic regions upon
reactivation. This event ultimately results in reduced level of
H3K27me3, which are concomitant with increasing levels of
activating histone marks on the RTA promoter. Furthermore,
treatment of latently KSHV-infected cells with a drug inhibiting
the expression of PcG proteins, the small inhibitory RNA-
mediated knockdown of EZH2 or the overexpression of
H3K27me3 histone demethylases efficiently trigger the lytic
reactivation of KSHV. These data collectively demonstrate that
the Polycomb group proteins are involved in the maintenance of
KSHV latency by preserving a reversible heterochromatin on the
promoter regions of lytic genes such that they are silenced during
latency but are poised for rapid activation upon reactivation.
Results
Dissociation of histone H3 from the KSHV genome is
concomitant with viral DNA replication
In this study we asked what histone modifications are associated
with the KSHV genome during latency and how they change
upon reactivation. For this, we used the well-characterized
recombinant KSHV-positive primary effusion lymphoma cell line,
TRExBCBL1-RTA, which expresses a Doxycycline (Dox) induc-
ible myc/His-tagged RTA incorporated into the cellular genome
[39]. We chose the RTA-mediated reactivation of KSHV instead
Author Summary
KSHV is a ubiquitous herpesvirus that establishes a life-
long persistent infection in humans and is associated with
Kaposi’s sarcoma and several lymphoid malignancies.
During latency, the KSHV genome persists as a multicopy
circular DNA assembled into nucleosomal structures. While
viral latency is characterized by restricted viral gene
expression, reactivation induces the lytic replication
program and the expression of viral genes in defined
sequential and temporal order. Posttranslational modifica-
tions of the viral chromatin structure have been implicated
to regulate viral gene expressions but the underlying gene
regulatory mechanisms are still elusive. Here, we demon-
strate that the latent and lytic chromatins of KSHV are
associated with a distinctive pattern of activating and
repressive histone modifications whose distribution
changes upon reactivation in an organized manner in
correlation with the temporally ordered expression of viral
lytic genes. Furthermore, we demonstrate that the
evolutionarily conserved Polycomb group proteins, that
maintain the repression of genes involved in hematopoi-
esis, X-chromosome inactivation, cell proliferation and
stem cell differentiation, also play a critical role in the
regulation of KSHV latency by maintaining a repressive
chromatin structure. Thus, the epigenetic program of KSHV
is at the crux of restricting latent gene expression and the
orderly expression of lytic genes.
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because these chemicals can globally affect both cellular and viral
gene expression, while RTA ensures robust and specific viral
reactivation [39]. Figure S1 showed that Dox treatment (1ug/ml)
of the TRExBCBL1-RTA cells for 6, 12 and 24 hours rapidly
induced myc/His-RTA expression, resulting in a gradual
induction of the KSHV gene expression cascade (Figure S1A, B)
[39], whereas viral DNA replication was apparent only at 24 hpi,
which was in correlation with the induction of late gene
expressions (Figure S1B and C). To analyse the changes in the
KSHV nucleosome structure upon reactivation, ChIP experiments
were performed with a histone H3 specific antibody. We measured
the abundance of specific DNA sequences in the histone H3
immunoprecipitates with qPCR using a set of primer pairs specific
for both the promoter and the coding regions of various viral genes
including RTA, LANA, K2, ORF8, ORF25, ORF56 and ORF64
(Figure S2A, B). This revealed comparable levels of H3 association
throughout the viral genome during latency (0 hpi), which did not
significantly change on most of the genomic regions at 12 hpi, but
dropped sharply at 24 hpi (Figure S2B). This is in agreement with
previous findings showing that disassembly of the viral chromatin
is concomitant with viral DNA replication during lytic infection
[40]. In contrast, H3 levels remained constant on cellular
promoters during KSHV lytic reactivation, suggesting that H3
dissociation occurs specifically on the viral genome (Figure S2C).
Distinct patterns of activating and repressive histone
modifications on the KSHV genome during latency and
reactivation
In order to investigate the epigenome of KSHV during latency
and lytic reactivation, we tested whether repressive histone
modifications associated with lytic genes are responsible for
maintaining the repression of lytic gene expression during latency
and whether reactivation induces the deposition of activating
histone modifications onto the viral genome for lytic gene
expression. To uncover the global distribution of histone
modifications on the KSHV chromatin during latency and
reactivation, we mapped the genome-wide distribution of
activating histone marks [acetyl-H3 (AcH3) and H3K4me3] and
repressive marks (H3K9me3 and H3K27me3) on the KSHV
genome (Figure 1 and Figure S3, S4, S5, S7). The ChIP-on-chip
experiments were carried out with chromatins prepared from both
non-induced (0 hpi/latency) and Dox-induced (12 hpi)
TRExBCBL1-RTA cells. Figure 1 shows the average of two
independent ChIP-on-chip biological replicates (Figure S3 and
Figure 1. Genome-wide mapping of histone modifications on the KSHV genome during latency and reactivation. Each ChIP-on-chip
experiment is an average of two biological replicates. The histone H3 and histone modification ChIPs were performed with non-induced and
doxycycline-induced (12 hpi) TRExBCBL1-Rta cells followed by the hybridization of the labelled ChIP and input DNAs onto a custom designed KSHV-
specific 15-bp tiling microarray. See the Material and methods for details. Orange colour indicates 0 hpi-ChIP/input ratio while the black line shows1 2
hpi-ChIP/input. Numbers in the left upper corners show the maximum values of Cy5/Cy3. Missing probes in specific genomic regions are shown
below the genome scale (**). The alternating dark and light blue squares atop display the viral ORFs where the white triangle indicates ORFs that are
expressed from the reverse DNA strand. The ‘‘hpi’’ stands for hours post-induction.
doi:10.1371/journal.ppat.1001013.g001
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modifications and proteins of interest on the KSHV genome, we
used a 15-bp tiling microarray that contains 8942 overlapping 60
nucleotide-long oligos spanning the entire KSHV genome.
Because changes in H3 occupancy may affect the enrichment of
histone modifications on the viral genome, we first investigated the
global distribution of H3 on the viral genome during latency and
upon reactivation. The histone H3 ChIP-on-chips revealed that
histone H3 enrichment levels were comparable throughout the
KSHV genome at 0 hpi and did not significantly change on most
parts of the KSHV genome at 12 hpi (Figure 1, S3, S4). The
histone H3 ChIP analysis also showed similar results (Figure S2B).
However, it should be noted that a small viral genomic region
between 15 and 30 kb, which contains mostly KSHV unique
genes, displayed a detectable decrease of H3 occupancy at 12 hpi
(Figure 1). In contrast to the uniform distribution of H3, the
different histone modifications displayed distinct patterns and were
enriched in specific KSHV genomic regions during latency and
reactivation (Figure 1). Immunoblot analysis revealed that the
expression of H3 as well as the global levels of cellular histone
modifications did not change upon KSHV reactivation (Figure S2
D), thus any change of the histone modifications on the KSHV
genome is likely to be a consequence of the reactivation-induced
change in the KSHV epigenome. The genome-wide mapping of
histone modifications showed that both activating and repressive
histone modifications were associated with the KSHV genome
during latency (Figure 1). While both the activating AcH3 and
H3K4me3 marks co-localized on the KSHV genome so did the
repressive H3K9me3 and H3K27me3 marks. However, the
activating and repressive histone modifications were mutually
exclusive on the bulk of the KSHV genome (e.g. 30–60 kb and
90–120 kb) (Figure 1). As expected, the latency-associated locus
(118–128 kb) where KSHV genes that are constitutively expressed
during latency are located, was enriched with the activating
H3K4me3 and AcH3 histone modifications but depleted for the
repressive H3K9me3 and H3K27me3 (Figure 1). Unexpectedly,
we also found that several regions of the KSHV genome (e.g. 1–
30 kb and 60–90 kb) that are not associated with latency-gene
expression were also highly enriched in both H3K4me3 and AcH3
histone marks (Figure 1). Strikingly, the PcG protein-mediated
repressive histone modification, H3K27me3, was widely distrib-
uted throughout the KSHV genome, whereas the H3K9me3
repressive histone modification was restricted mainly to two
genomic regions (30–60 kb and 95–115 kb) encoding a number of
late genes (Figure 1). Interestingly, the activating H3K4me3 and
AcH3 histone modifications were absent in these two genomic
regions where the repressive H3K9me3 and H3K27me3 histone
modifications coexisted, suggesting that KSHV genes in these
regions have a strongly repressive heterochromatin structure
during latency (Figure 1).
The RTA-induced initiation of KSHV lytic gene expression
program results in the redistribution of histone modifications on
viral genome. We calculated the 12hpi/input ratio to view the
changes in histone modifications (Figure 1). Since H3 enrichment
was comparable between 0 and 12 hpi on most parts of the viral
genome and viral DNA replication had yet to occur by 12 hpi, we
also hybridized the 12 hpi-ChIPs against the 0 hpi-ChIPs, which
allowed us to specifically observe changes in histone modification
levels on the KSHV genome upon lytic reactivation (Figure S7C).
Others have also recently applied similar ChIP-on-chip analyses in
studies investigating the epigenetic reprogramming of the host
genome by the adenoviral protein E1a [41]. Our ChIP-on-chip
analysis showed that the enrichment of the activating histone
modifications was elevated the most when it was concomitant with
the reduction of repressive histone marks in the genomic regions
between 1 and 30 kb containing several early genes and between
68 and 77 kb, which encodes the IE proteins ORF45, ORF48,
ORF50 (RTA) and K8 (KbZIP) (Figure 1 and S7). These changes
in the viral chromatin are indicative of robust transcriptional
activation and are consistent with the KSHV gene expression
profile in that expression of the lytic genes in these genomic
regions is induced in the early phase of reactivation [39,42,43]. In
contrast, only minor changes in the levels of the AcH3 and
H3K4me3 activating marks were detected in the genomic regions
that encode large number of late genes (30–60 kb and 95–115 kb),
whereas significant changes of the H3K27me3 repressive mark
were observed at 12 hpi (Figure 1 and S7).
In summary, these results demonstrate that the activating
histone modifications of the latent KSHV genome are preferen-
tially enriched in the constitutively active latency-associated
genomic locus and in the early-lytic gene-containing genomic
regions. In contrast, the H3K9me3 and H3K27me3 repressive
histone marks are primarily enriched in the genomic regions that
encode many late genes during latency (0 hpi), and they remain
associated with these regions during the early phase (12 hpi) of
reactivation as well.
Profiling the histone modification patterns within the
regulatory regions of KSHV genes
While only a few genes are expressed during latency, all viral
genes are expressed upon lytic reactivation in a temporal and
sequential order. This suggests that distinctive histone modifica-
tions may be associated with the different viral promoters to
ultimately determine the timing and rate of viral gene expression.
Thus, we attempted to delineate the characteristics of the
chromatin structures associated with the regulatory regions of
KSHV genes during latency and lytic reactivation (Figure 2, S6,
S8). For this, we aligned the KSHV open reading frames (ORFs)
relative to their translational start sites (TSS) and plotted the signal
intensities of probes derived from the ChIP-on-chip analysis across
a 2-kb region spanning 1 kb on either side the TSS (please see
Materials and Methods for details). The rationale of this strategy
was based on a number of considerations. (i) While the
transcriptional start sites have only been identified for a few
KSHV genes, they are generally within a few hundred base pairs
of their TSS, showing that the TSS can be used as a reference
point. (ii) Due to the compact structure of the KSHV genome, the
promoters are usually closely localized upstream of the TSS. (iii)
The 1 kb downstream region of the TSS was included in the
analysis because several KSHV genes have introns close to the
TSS at their 59 ends, which may contain gene regulatory elements.
Based on these factors, the 2-kb sequences around the TSS were
considered to be the gene regulatory regions of KSHV genes. In
fact, a similar strategy has also been used to analyse the
recruitment of the KSHV transactivators, Rta and K-bZIP, to
eighty-three putative KSHV promoters in TRExBCBL1-RTA
cells [44]. Using the signal intensities of the probes derived from
the ChIP-on-chip analysis, we performed an average linkage
hierarchical clustering within each gene class (La or latent, IE, E,
L), which gave us a comprehensive overview of the repressive and
activating histone modifications across all the 2-kb TSS regions
(Figure 2 and S8).
IE gene class. By definition, IE genes are the first set of
expressed viral genes whose induction does not require de novo
expression of any viral proteins and can be rapidly induced upon
reactivation of KSHV from latency. We found that although the
IE genes (K4.2, K8, ORF45, ORF48, ORF50/RTA) are silenced
during latency, their 2-kb regulatory regions are enriched in the
Epigenetic Analysis of the KSHV Genome
PLoS Pathogens | www.plospathogens.org 4 July 2010 | Volume 6 | Issue 7 | e1001013Figure 2. Hierarchical clustering of histone modifications associated with the regulatory regions of viral genes. Based on their
expression patterns the viral genes were grouped as latent (La), IE, E and L genes and hierarchical clustering was performed within the groups. The
rows display the histone modification patterns along the 21k bt o+1 kb genomic regions relative to the translational start site (TSS) of each viral
gene, which we assigned for the gene regulatory regions. The 1 kb regions are divided into twenty 50 bp fragments that show the average of log2
ratio of probe signal intensities derived from the average of the biological replicates of ChIP-on-chip experiments. Blue and yellow colours represent
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further increased upon lytic reactivation at ORFs 48, 50 and K8
(Figure 2, S8, S9). Since RTA is responsible for the switch between
latency and lytic replication, not only is its promoter tightly
repressed during latency, but its silencing should also be rapidly
reversible upon reactivation. We found that the RTA promoter is
enriched in both H3K4me3 and H3K27me3 during latency,
suggesting that it possesses a bivalent chromatin that maintains the
repression of the RTA promoter while keeping it poised for rapid
activation (Figure 2, S8). An extensive ChIP analysis further
confirmed the enrichment of AcH3, H3K4me3 and H3K27me3
and the depletion of H3K9me3 on the 2.5-kb promoter region of
RTA during latency (Figure 3A). Upon lytic reactivation, however,
the repressive H3K27me3 gradually decreased, while the
activating histone modifications H3K4me3 and AcH3 increased
on the RTA promoter (Figure 3A). These changes in the histone
modification pattern are in concert with the induction of RTA
expression.
To confirm that the changes in the enrichment of AcH3,
H3K4me3 and H3K27me3 were not due to differences in the
efficiency of ChIPs between 0 and 12 hpi and that the low level of
H3K9me3 was not due to a low efficiency of the H3K9me3-ChIP,
three cellular promoters were also included as controls. Figure 3D
shows that the levels of histone modifications on the transcrip-
tionally repressed promoters of MYT1 and HTF6 genes as well as
on the transcriptionally active promoter of the actin (ACT) gene
did not significantly change between 0 hpi and 12 hpi, indicating
that the efficiencies of the ChIPs were comparable at different time
points (Figure 3D).
Bivalent chromatin on the RTA promoter during
latency. Although .95% of non-induced TRExBCBL1-RTA
cells were in latency, a few percentages of the cells spontaneously
underwent lytic reactivation as measured by the surface expression
of the early viral protein ORF K1 in flow cytometry analysis (data
not shown). Thus, this raises the possibility that the colocalization
of H3K4me3 and H3K27me3 histone modifications at the same
genomic region may be due to the mixture of latent and
spontaneously reactivated KSHV genomes in the ChIPs assays.
To determine whether H3K4m3 and H3K27me3 on the RTA
promoter were simultaneously on the same KSHV genome and
not independent histone marks on different viral genomes,
sequential ChIP assay was applied (Figure 3B). We performed
the first ChIP with an anti-H3K4me3 antibody, followed by the
elution of the immunoprecipitated chromatin, which was then
used in a second ChIP with an anti-H3K27me3 antibody. The
ChIP DNAs were measured by qPCR, using specific primers for
the promoter regions of RTA, LANA and ORF25 genes. This
showed that both H3K4me3 and H3K27me3 were enriched only
on the RTA promoter (Figure 3B, top panel). The reciprocal order
of the ChIPs gave the same results (Figure 3B, bottom panel). The
promoter regions of LANA and ORF25 were included as controls
and showed the presence of either H3K4me3 or H3K27me3,
respectively, but not both (Figure 3B). These data collectively show
that the H3K4me3 and H3K27me3 associated with the RTA
promoter coexist on the same KSHV genome, indicating that the
RTA promoter appears to possess a bivalent chromatin.
Early gene class. Expression of IE genes is followed by the
induction of E genes that encode a large variety of proteins for
modulating immune responses, apoptosis or performing viral
DNA synthesis. From the analysis of the TSS/promoter regions of
E genes, three subgroups (I, II and III) of histone modification
patterns emerged (Figure 2, S8). Group I: some of the E genes also
seem to have a bivalent chromatin structure on their 2-kb putative
regulatory regions during latency. Upon reactivation, this changes
to fully active euchromatin with increased activating and
decreased repressive histone modifications on their promoter
(Figure 2, S8). Group II: the promoter regions of the majority of E
genes are associated only with AcH3 and H3K4me3 but depleted
for the repressive marks during latency (Figure 2, S8).
Interestingly, groups I and II consist of a number of E genes
that are involved in the deregulation of host immune response
(K1/3/5/15, ORFs 10, 11) and/or KSHV pathogenesis (K2/4.1/
6/9, ORF74) (Figure 2, S8). Group III: this group represents a
cluster of E genes that are enriched in H3K27me3 and H3K9me3
but depleted for activating histone modifications during latency,
which does not change significantly upon reactivation. It should be
noted that the histone modification pattern of Group III genes
resembles that of Group IV late genes, even though their
expression patterns are considerably different during KSHV
lifecycle. The above findings were further confirmed in
independent ChIP experiments analysed by qPCR using specific
primers for the K2 and ORF56 promoter and coding regions
(Figure 3C).
Late gene class. The KSHV genes whose expression can be
blocked by viral DNA replication inhibitors are classified as late
genes. Because most of the late gene products are necessary for the
assembly and egress of viral particles, their expression is required
only after viral DNA synthesis. To achieve this temporal order of
viral gene expression they should be completely silenced during
the expression of IE and E genes. In agreement with this notion,
we found that the promoter regions of most of the late genes were
enriched in the repressive H3K27me3 and H3K9me3 histone
modifications and depleted in the activating histone marks during
latency and in the early phase of the reactivation (12 hpi) (Figure 2,
S8, group IV). In contrast, the TSS regions of some late genes (e.g.
ORFs 39, 8, 47, 75) are associated with high levels of activating
and low levels of repressive histone modifications during latency,
which slightly changed during reactivation (Figure 2, S8, group V).
It is also worth noting the difference in location between groups IV
and V late genes on the KSHV genome, which may explain their
distinct chromatin structures. The group IV late genes, which are
highly enriched in repressive histone modifications, are clustered
in the 30–60 kb and 95–115 kb genomic regions (see Figure 1B).
On the other hand, the few L genes in the group V are scattered
throughout genomic regions enriched with activating histone
modifications. These results were further confirmed by a series of
ChIP experiments of the promoter and coding regions of three late
genes: ORF8 (group V), ORF25 (group IV, 30–60 kb) and
ORF64 (group IV, 95–115 kb) (Figure 3C). These observations
suggest that late genes can be regulated by distinctive mechanisms
depending on their location on the KSHV genome.
Latent gene class. In agreement with the observed constitutive
expression of the latent genes (LANA and vIRF3) during latency,
their 2-kb TSS regions display enrichment only in H3K4me3 and
AcH3 while lacking repressive histone modifications (Figure 2).
Interestingly, while H3K4me3 enrichment decreased somewhat,
lower-than-average and higher-than-average for enrichment, respectively, whereas gray shows missing values for enrichment due to lack of probes in
those genomic regions. I-V represents the clusters of genes that have similar histone modification patterns. (A) Distinctive histone modification
patterns are associated with the KSHV genes of different expression classes during latency. (B) Changes in the enrichment of histone modifications
during reactivation (12hpi).
doi:10.1371/journal.ppat.1001013.g002
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reactivation (Figure 3C). This was also confirmed by additional
independent ChIP experiments with qPCR analysis focusing on the
specific locations within the LANA promoter and coding regions
(Figure 3C).
In summary, we described the chromatin modification
patterns of the TSS regions of the four expression classes
(Latent, IE, E, and L) of KSHV genes during latency and lytic
reactivation. Based on these data we propose that the diversity
of the chromatin structure of the KSHV genome can reflect the
various regulation mechanisms of viral gene expression, which
allows a temporal and well-organized gene expression during
reactivation.
Dynamic association of the Polycomb group proteins
and transcriptional activators with the KSHV genome
during latency and lytic reactivation
Because of the genome-wide distribution of H3K27me3 on the
KSHV genome, we performed a ChIP-on-chip assay to determine
whether EZH2, the H3K27me3 histone methyltransferase of the
PcG proteins, associates with the KSHV genome. (Figure 4A).
ChIP-on-chip assays showed that EZH2 almost completely
colocalized with H3K27me3 throughout the entire KSHV
genome during both latency and reactivation (Figure 4A, S7,
S10). Additional ChIP assays showed that EZH2 and SUZ12
(another subunit of the PcG complex PRC2) were found on the
RTA and ORF25 promoters enriched with H3K27me3, but not
on the LANA promoter (Figure 4B).
Besides its regulatory role in cellular gene expression, the
CBF1 transcription activator has been shown to play an active
role in KSHV gene expression as well [45,46]. Since the RTA
promoter contains several CBF1 binding sites (Figure S11 A)
[47,48], we studied the recruitment of CBF1 onto the RTA
promoter during reactivation. The ChIP assay showed that
CBF1 was recruited to the RTA promoter, primarily at 1.4 kb
upstream of the RTA translational start site where three
putative CBF1 binding sites are closely located (Figure 4C and
Figure S11 A). Furthermore, not only does this putative CBF-
binding region of RTA promoter efficiently binds CBF1 in vitro,
but its deletion also resulted in a dramatic decrease of the RTA-
mediated autoactivation of its own promoter (Figure S11 B, C).
Additional ChIP experiments revealed that RNAPII is also
recruited to the promoter regions of RTA and LANA upon
reactivation (Figure 4C). Recruitments of CBF and RNAPII to
the RTA and LANA promoters were specific since they were
not recruited to the promoter of the late gene, ORF25, whose
expression was still blocked at 6 and 12 hpi (Figure 4C and
S1B). The increase of RNAPII over the 3-kb upstream region of
RTA may be not surprising given that this genomic region also
includes the promoters of other lytic genes (ORFs 45, 46, 47, 48)
as well as an alternative upstream promoter for RTA [49].
These results illustrate the dynamic associations of the PcG
complex and transcriptional activators with KSHV genome
during latency and lytic reactivation.
Polycomb group protein EZH2 and its H3K27me3 histone
mark are required for the maintenance of KSHV latency
The dynamic association of EZH2 with KSHV genome suggests
that PcG-mediated H3K27me3 histone modification is involved in
the repression of lytic gene expression during latency. To address
this issue, HA-tagged JMJD2A, JMJD3 and UTX histone
demethylases were expressed in Vero-rKSHV.219 cells to test if
the elimination of histone methylations can trigger KSHV
reactivation (Figure 5A). JMJD2A is an H3K9me3-specific histone
demethylase [50], JMJD3 and UTX are H3K27me3-specific
histone demethylases [21,51], and UTXmut is an enzymatically
inactive form of UTX that contains a single point mutation
(H1146A) in the Fe
2++ ion binding site [51]. JMJD3 and UTX
have been shown to eradicate the H3K27me3 repressive mark,
resulting in the upregulation of PcG-targeted gene expression
[21,52]. JMJD2A and JMJD3 or UTX expression detectably
suppressed the steady-state levels of H3K9me3 or H3K27me3,
respectively, in transfected Vero cells (Figure S12B, C). Since
Vero-rKSHV.219 cells express red fluorescent protein (RFP) from
the KSHV lytic PAN promoter and green fluorescent protein
(GFP) from the EF-1a promoter, RFP expression has been
extensively used as a marker of KSHV lytic reactivation [53].
Immunofluorescence analysis revealed that JMJD3 and UTX
efficiently triggered KSHV reactivation, while JMJD2A and
UTXmut did not (Figure 5A, B). Furthermore, coexpression of
JMJD2A and JMJD3 showed no significant synergistic effect on
KSHV reactivation (Figure 5A, B). Finally, JMJD2A, JMJD3,
UTX and UTXmut were expressed at comparable levels (Figure
S12A). These results bespeak the importance of the H3K27me3
histone modification in the maintenance of KSHV latency.
A small molecule, 3-Deazaneplanocin A (DZNep), has been
shown to inhibit the expression of the Polycomb repressive
complex 2 (PRC2) components (EZH2, SUZ12, and EED),
resulting in the suppression of H3K27me3 histone methylation
and the upregulation of PcG target genes in vivo [54]. To further
test the role of H3K27me3 histone methylation in KSHV latency,
we treated KSHV and EBV co-infected primary effusion
lymphoma JSC-1 cell line with DZNep, followed by immunoblot-
ting assays (Figure 5 C and D). DZNep treatment dramatically
decreased the EZH2 and SUZ12 and, thereby, H3K27me3 levels,
ultimately resulting in the induction of the expression of
polycomb-targeted cellular MYT1 gene (Figure 5E). However,
H3K9me3, histone H3, and actin levels were not affected under
the same conditions (Figure 5C). We found that DZNep treatment
efficiently induced the reactivation of KSHV, but not EBV:
KSHV Rta and K8 expressions were detected as early as 2 days
after DZNep treatment, while the EBV IE protein Zta was not
induced (Figure 5D). Real time quantitative RT-PCR also showed
the induction of other early (ORF56) and late KSHV genes (ORFs
8, 25, 64), suggesting that PRC2 depletion activates the gene
expression cascade of KSHV from the repressed latent state
(Figure 5E).
Besides the downregulation of EZH2 and SUZ12, DZNep also
induced apoptosis of JSC-1 cells, detected by monitoring the
Figure 3. Dynamic association of histone modifications with viral genes during latency and reactivation. (A) Time-course ChIP analysis
of histone modifications on the RTA promoter during latency and reactivation. Cellular controls can be seen in panel D. (B) Colocalization of
H3K4me3 and H3K27me3 on the RTA promoter is confirmed by sequential ChIP assays. The first ChIP was performed with either H3K4me3-specific or
H3K27me3-specific antibody, followed by the elution of the immunoprecipitated DNAs and a second ChIP with either H3K27me3 or H3K4me3
antibody. LANA and ORF25 promoters were used as controls. (C) Time-course ChIP analysis of histone modifications on the selected latent (LANA),
early (K2, ORF56) and late (ORFs 8, 25, 64) genes. Cellular controls can be found in panel D. Pr: promoter, in: within gene body. (D) ChIP assays of
histone modifications on cellular promoters. The promoters of the repressed cellular MYT1 and HTF6 genes as well as the active promoter of the actin
(ACT) gene were also tested using the same ChIP samples that had been used in panels A and C. ND: not detectable.
doi:10.1371/journal.ppat.1001013.g003
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exclude the possibility that apoptosis may have influenced KSHV
reactivation, we treated JSC-1 with stauorosporine (STS), which
also induced apoptosis in JSC-1 as shown by the cleavage of PARP
(Figure S13 C). In contrast to DZNep treatment, STS treatment
affected neither the steady state levels of EZH2 and H3K27me3,
nor did it reactivate KSHV from latency (Figure S13 C, D). This
suggests that DZNep-mediated H3K27me3 reduction triggers
KSHV reactivation. This was further supported by the fact that
specific shRNA-mediated depletion of EZH2 induced the
expression of number of lytic genes (Figure 5F, G). In summary,
the depletion of the PcG proteins in latently infected cells induces
the lytic reactivation of KSHV, suggesting that PcG proteins play
an important role in the maintenance of KSHV latency.
Figure 4. Genome-wide binding of EZH2 to the KSHV genome correlates with the repression of lytic genes. (A) ChIP-on-chip was
performed for EZH2 and its genome-wide binding was compared with the distribution of H3K27me3 on the KSHV genome during both latency and
reactivation. Labels are the same as in Figure 1. The H3K27me3 graph was taken from Figure 1. (B) EZH2 and SUZ12 binding to the H3K27me3-rich
lytic promoters are shown by independent ChIP assays. EZH2-interacting PcG protein SUZ12 is enriched only where EZH2 is present. (C) Recruitment
of transcription activators to the activated lytic promoters during KSHV reactivation. An anti-RNA polymerase II antibody (H-224) that recognizes the
RNAPII independently from its phosphorylation state (total RNAPII) was used for ChIP of total RNAPII, while the anti-RNA polymerase II antibody
CTD4H8 specifically immunoprecipitates RNAPII phosphorylated at the 5
th serine of its C-terminal domain (RNAPII Ser5).
doi:10.1371/journal.ppat.1001013.g004
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The genome-wide transcriptional analysis of KSHV gene
expression revealed that despite the differences in the features of
their promoters, viral genes with similar functions display
analogous expression patterns during the lytic replication cycle,
implying the existence of a common regulatory mechanism for
their gene expression [39,42,43,55]. In fact, cellular genes with
related functions often have common chromatin structures that
are associated with specific histone modifications whereby
expression of large sets of genes can be coherently coordinated
by epigenetic mechanisms [56]. Our ChIP-on-chip analysis
identifies several distinct chromatin domains with different histone
modifications on the latent KSHV genome, suggesting that
expression of viral genes within each chromatin domain may be
co-regulated (Figure 1, 2, S7, S8). Specifically, latent genes
clustered in the latency-associated genomic locus have H3K4me3/
AcH3-rich chromatin domain during latency and reactivation,
which is in correlation with the constitutively active transcription
of latency-associated genes. The genomic region encoding the IE
genes ORF50 and ORF48 has a bivalent chromatin domain
defined by the concomitant presence of the activating H3K4me3
and the repressive H3K27me3 marks during latency, which
rapidly changes upon reactivation with increasing AcH3 and
H3K4me3 and decreasing H3K27me3 (Figure 2, 3A). Important-
ly, the chromatin bivalency of the RTA promoter ensures the
repression of RTA during latency, but also readies it for rapid
activation upon reactivation (Figure 3A, S1). Bivalent chromatin is
characteristic of many inducible cellular genes that are involved in
the regulation of development and immune responses such that
these genes are repressed yet primed for rapid activation [7,15].
KSHV genomic regions encoding a number of late genes are
associated with repressive H3K9me3 and H3K27me3 modifica-
tions during both latency and the early phase of lytic reactivation,
which is in accordance with the observed silencing of late genes.
Strikingly, the high expression of late genes is observed at the time
of the viral DNA replication concomitantly with the disassembly of
viral chromatin (Figure S1, S2). These data suggest that viral DNA
replication may play a role in the disruption of the repressive
heterochromatin associated with viral late genes, which ultimately
facilitates late gene expression [40]. However, a recent study has
shown that a portion of replicating herpesviral genomes can be
chromatinized even during lytic replication, indicating that viral
chromatin may be continuously involved in the regulation of late
gene expression [57]. In addition, the deletion of several MHV68
genes has been shown to result in blocking of late gene expressions
without affecting viral DNA replication [58,59,60]. This suggests
that viral replication may not directly influence the disassembly of
the heterochromatin of late genes.
Based on the histone modification patterns associated with the
promoter regions of E genes, three distinctive groups could be
observed (Figure 2, S8). The chromatin structure of the promoters
of Group I genes resembles that of cellular bivalent promoters with
the exception that they are also enriched in H3K9me3 during
latency. However, the depletion of H3K9me3 is contemporaneous
with the decrease of H3K27me3 upon reactivation, suggesting that
both repressive histone marks are replaced by activating histone
marks upon reactivation. The promoters of Group II genes are
enriched primarily with activating histone modifications during
both latency and reactivation, similar to those of IE genes, whereas
the promoters of most Group III genes are mainly associated with
repressive histone marks during latency and in the early phase of
reactivation (12 hpi), resembling Group IV late genes. This
indicates that despite the different gene expression profiles during
the lytic reactivation cycle, some of the lytic genes show similar
histone modification patterns in their promoters, suggesting that
other histone modifications may be also associated with these
promoter regions to generate the distinct gene expression profiles.
This topic will be actively investigated in the future. Furthermore,
our observation that the TSS regions/promoters of several E genes
are enriched with the activating AcH3 and H3K4me3 histone
marks but depleted for the repressive histone modifications during
latency, suggests that although transcription of these E genes may
have been initiated, RNAPII is likely stalled on their promoters
(Figure 2 and 3C). In fact, several of these E genes (K2, K5, K6,
K7, K11) have been shown to be temporally expressed
immediately after de novo infection or rapidly express upon lytic
reactivation [55,61]. These E genes carry immune modulatory
and/or antiapoptotic functions so their rapid expressions seem to
be crucial for the virus to escape host immune recognition or
attack during the early phase of the lytic life cycle of KSHV. This
suggests that their promoters are primed with activating histone
modifications and probably have preassembled RNA polymerase
II complexes during latency as also seen with a large number of
inducible cellular genes [7,62]. However, this raises the question of
how their gene expressions are suppressed during latency despite
the presence of an active chromatin structure. It is intriguing that a
large number of the E genes that are enriched primarily with
AcH3 and H3K4me3 activating marks are also Rta-inducible,
suggesting that the cooperation of Rta with the active chromatin
structure may be necessary to activate expression of these E genes.
Furthermore, it is conceivable that the stalled RNAPII on their
promoters also requires the recruitment of specific cellular
transcription factors such as PTEFb, in order to allow the
conversion of RNAPII from a restricted state to an elongation-
competent state [62].
Histone H3 ChIP-on-chip revealed that a small viral genomic
region (between 15 and 30kb) mostly containing KSHV unique
genes displayed a detectable decrease of H3 occupancy at 12hpi
(Figure 1). Thus, the decrease of the repressive H3K27me3 histone
mark within this region upon reactivation may potentially be a
consequence of the dissociation of H3 occupancy. However, the
decrease of H3 occupancy in this region does not directly correlate
with the changes in histone modifications as H3K27me3 decreases
in both 15–20kb and 25–30kb regions at 12 hpi, but while
H3K4me3 and AcH3 increase in the 15–20kb region (ORFs 10,
11, 70, K3) they decrease in the 25–30kb region (ORFs K5, K6,
K7, PAN). Thus, changes in enrichment of histone modifications
Figure 5. Polycomb group proteins are involved in the maintenance of latency of KSHV. (A) Overexpression of the wild-type HA-tagged
H3K27me3 histone methyltransferases (HMTs) UTX and JMJD3 triggers the lytic reactivation of KSHV in Vero-rKSHV.219 as shown with the expression
of RFP. In contrast, the H3K9me3 HMT JMJD2A and the enzymatically inactive UTXm showed little or no effect on KSHV lytic reactivation. (B)
Quantification of RFP positive cells. (C and D) JSC-1 cells were treated with 5 uM DZNep for 1, 2 and 3 days and the cells were harvested for
immunoblot analysis with the indicated specific antibodies against cellular proteins and histone modifications (C) or viral proteins (D). ‘‘Dpt’’ indicates
days post-treatment. Whole cell lysate of NaB-treated JSC-1 cells was used as a control for Zta immunoblot. (E) JSC-1 cells were treated with DZNep as
described in (C) and total RNAs were isolated for RT-qPCR analysis of some selected KSHV, EBV and cellular mRNAs. (F and G) BCBL-1 cells were
infected by lentivirus expressing the indicated shRNAs and were then subject to immunoblotting analysis with the indicated antibodies (F) or RT-
qPCR analysis was performed for the indicated viral transcripts (G).
doi:10.1371/journal.ppat.1001013.g005
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changes in nucleosome occupancy.
In contrast to the genome-wide repressive role of H3K27me3,
the effect of the heterochromatin histone mark H3K9me3 on viral
gene expression seems to be limited: enrichment of the H3K9me3
is restricted to specific genomic regions (Figure 1) and the
H3K9me3 histone demethylase JMJD2A does not efficiently
induce KSHV lytic replication in Vero cells (Figure 5A). However,
it is possible that JMJD2A expression may induce KSHV
reactivation in different cell types or H3K9me3 histone demethy-
lases other than JMJD2A may contribute to KSHV reactivation
[50]. This is in agreement with the Herpes simplex virus (HSV-1)
latent genome: while the H3K9me2, H3K9me3, and H3K27me3
modifications are detected, all the tested viral promoters are most
enriched in H3K27me3 [63]. On the other hand, the inhibition of
the H3K9me3 histone demethylase LSD1 has been shown to
block the reactivation of HSV-1 from latency [30], and the
enrichment of H3K9me3 and relatively low levels of H3K27me3
were found on the latent genome of the gammaherpesvirus EBV
[64,65]. These studies indicate that H3K9me3- and H3K27me3-
associated chromatin-based repression mechanisms may be a
common feature of herpesvirus gene expression programs.
Genome-wide co-distribution of the EZH2 with the H3K27me3
repressive mark on lytic genes of KSHV and the EZH2
knockdown-mediated induction of lytic gene expression strongly
implicate PcG proteins in the repression of lytic gene expression
during latency (Figure 4, 5, S7, S10). Interestingly, our ChIP-on-
chip analyses also showed that, correlating with the rise of EZH2
occupancy, H3K27me3 levels increased mostly on late gene-rich
regions (30–50 kb and 105–115) during lytic reactivation. We
hypothesize that in order to maintain a temporally ordered
expression of lytic genes, late gene expression may be kept silenced
by PcG proteins during the early gene expression period, and this
repression is likely reversed only upon replication of the viral
genome (Figure S1 and S2). In contrast, H3K27me3 levels
significantly dropped in the 15–30kb region of the viral genome at
12 hpi, which correlates with the decrease of EZH2 binding and
the dissociation of H3. Thus, decreased H3K27me3 levels may be
due to the dissociation of nucleosomes, the dissociation of EZH2
and/or the recruitment of H3K27me3 histone demethylases.
Nevertheless, these data suggest that the regulation of spatial and
temporal association of the PcG proteins with the KSHV genome
may be crucial for both KSHV latency maintenance and lytic
reactivation. Indeed, SUZ12 as well as EZH2, the H3K27me3
histone methyltransferase of PcG proteins, extensively associate
with the RTA promoter during latency, while EZH2 rapidly
dissociates from the RTA promoter upon reactivation, which is in
apparent correlation with the decrease of H3K27me3 levels and
the increase of RTA expression (Figure 3A, 4B and S1). Several
studies have shown that PcG proteins are recruited to their target
promoters through specific DNA elements, transcription factors or
non-coding RNAs, which leads to the condensation of nucleo-
somes, the inhibition of RNAPII elongation, and thereby repress
the expression of their target genes [16,18,19,20,66,67,68,69].
Several cellular and viral proteins, K-RBP, KAP-1 and LANA, are
involved in the maintenance of KSHV latency, suggesting that
they may be potential recruiters of PcG proteins onto the KSHV
genome [70,71,72]. Further studies are needed to clarify how
EZH2 is recruited to the KSHV genome and how EZH2 binding
is modulated during reactivation. Recently, it has been also shown
that BMI, a subunit of the polycomb repressive complex PRC1, is
recruited onto lytic HSV-1 promoters during latency [63,73].
Thus, the roles of PcG proteins in herpesvirus latency remain
under active investigation.
Derepression of the PcG proteins-mediated silencing of gene
expression have been linked to the recruitment of the H3K27me3
histone demethylases UTX and JMJD3 and the H3K4me3 histone
methyltransferases MLL3 and MLL4 onto the target promoters,
suggesting a tight cooperation between demethylation of the
H3K27 and trimethylation of the H3K4 [23,74]. We also found
that overexpression of either UTX or JMJD3 resulted in the
efficient reactivation of KSHV, suggesting that H3K27me3
histone demethylases release the PcG-mediated repression of lytic
gene expressions (Figure 5A). Furthermore, our ChIP analysis
(Figure 4C) indicates that along with the histone acetyltransferase
CBP, the chromatin remodelling complex SWI/SNF, and the
TRAP/Mediator complex [34,38], cellular transcription factors
CBF1 and RNAPII are also recruited onto the RTA promoter to
induce its gene expression. Taken together, PcG proteins are
deposited on the RTA promoter to suppress transcription of RTA
during latency, whereas upon reactivation, the resetting of histone
modifications, remodelling of the chromatin structure, and the
recruitment of a large set of transcription cofactors result in the
activation of RTA gene expression.
Collectively, our results indicate for the first time that histone
modifications associated with the latent KSHV genome can be
involved not only in the regulation of latency, but also in the
control of the temporal and sequential order of the lytic gene
expression cascade of KSHV upon reactivation. PcG proteins
appear to play a key role in the maintenance of latency as well as
in the inhibition of late gene expression during the early phase of
lytic reactivation. Besides these beneficial roles of PcG proteins for
the viral lifecycle, KSHV may adjust its viral genome through
epigenetic modifications to tightly regulate viral expression to
avoid promiscuous expression of lytic genes, which may trigger
host immune system responses against KSHV infected cells.
Materials and Methods
Cell cultures and chemical treatments
TRExBCBL1-RTA is a KSHV-positive cell line, which
expresses a doxycycline-inducible Rta gene [39]. It was main-
tained in RPMI 1640 medium (Cellgro) supplemented by 10% Tet
system approved FBS (Clontech), 100 U/ml penicillin, 100ug/ml
streptomycin and 20ug/ml hygromycin B. KSHV- and EBV-
positive cell line JSC-1 was grown in RPMI 1640 medium
(Cellgro) containing 10% FBS (Clontech), 100 U/ml penicillin
and 100ug/ml streptomycin. For 293A, HeLa and Vero-
rKSHV.219 cell lines DMEM medium (Invitrogen) containing
10% FBS (Clontech), 100 U/ml penicillin and 100ug/ml
streptomycin was used. 1 ug/ml of Doxycycline (Dox) was used
to induce the expression of myc/His-tagged Rta in TRExBCBL1-
RTA. JSC-1 was stimulated with 5, 1, 0.2 or 0.04 uM of 3-
deazaneplanocin (DZNEP) or 200 nM of staurosporine (STS).
Plasmids, transfection and luciferase assay
Expression plasmids HA-JMJD3 and HA-UTX were obtained
from Kristian Helin (University of Copenhagen). HA-JMJD2A
expression vector was gift from Yang Shi (Harvard University).
HA-UTXm was generated by replacing the C terminus of the
UTX in HA-UTX with PCR cloning to change histidine to
alanine at amino acid 1146. pLuc3kb, pLuc1.9kb and pLuc0.9kb
reporter plasmids were generated by inserting the Luciferase gene
derived from pGL3-Basic and different sized fragments of the
promoter region of KSHV Rta into pcDNA5/FRT. 293A and
Vero.219 cells were transfected by Polyfect (Qiagen) according to
the manufactrer’s specifications. Luciferase assay was performed
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average of at least three independent experiments.
Immunofluorescent analysis
Vero cells were transfected with plasmids expressing HA-tagged
JMJD2A, JMJD3, UTX or UTXm respectively. 3 days post
transfection, cells were fixed by 4% paraformaldehyde and then
permeabilized by 0.2% Triton X100. 10% goat serum was used
for blocking aspecific binding of antibodies followed by incubation
of cells with antibodies against HA-tag, H3K9me3 and
H3K27me3. After extensive washing with PBS, FITC- and
TRITC-conjugated secondary antibodies were applied followed
by Hoechst staining.
DNA affinity purification assay
Biotinylated DNA was made with biotin-conjugated primers
and PCR amplification of sequences that are derived from the
KSHV RTA promoter. KSHV (U75698.1 at GenBank) coordi-
nates for fragment A and B are 69861–70500 and 70511–71130,
respectively. The assay was performed essentially as described by
Atanasiu et. al. [75] except that streptavidine resin (Stratagene)
was used to pull down the DNA/protein complexes and proteins
were eluted from the streptavidine resin with Laemmli sample
buffer (Sigma).
Antibodies for ChIPs and western blotting
The following antibodies were used in ChIPs and/or western
blotting: rabbit anti-histone H3 (Abcam ab1791), rabbit anti-
H3K27me3 (Millipore 07-448), rabbit anti-H3K9me3 (Millipore
07-442), rabbit anti-H3K4me3 (Millipore 04-745), rabbit anti-
acetyl-histone H3 (AcH3) (Millipore 06-599), rabbit anti-RNA
polymerase II (H-224) (total RNAPII) (Santa Cruz sc-9001), mouse
anti-RNA polymerase II (CTD4H8) (RNAPII Ser5) (Millipore 05-
623), rabbit anti-CBF1 (Abcam ab25949), mouse anti-EZH2 (BD
Biosciences 612666), rabbit anti-SUZ12 (Abcam ab12073). For
western blotting the following antibodies were used: mouse anti-
PARP (BD Biosciences 556494), mouse anti-actin (Abcam), anti-
JMJD2A (Bethyl A300-861A), anti-JMJD3 (Abgent AP1022a),
KSHV specific antibodies such as mouse anti-Rta gift from Koichi
Yamanishi (Osaka University, Japan), rabbit anti-K8.1, mouse
anti-K8 (Abcam ab36617), rabbit anti-K2 (ABI 13-214-050), rat
anti-LANA (ABI 13-210-100), Epstein Barr Virus specific antibody
such as mouse anti-Zebra (Zta) (Argene 11-007).
Chromatin Immunoprecipitation assay (ChIP)
TRExBCBL1-RTA cells (4610
7) were treated for 6, 12 and
24 hr with 1 ug/ml doxycycline. After fixation of the cells with 1%
(v/v) formaldehyde for 10 min at RT, the cross-linking was
stopped by adding glycine (final concentration 125 mM) for 5 min
at RT. Cells were washed (36) with cold PBS and then
resuspended in Cell Lysis Buffer (5 mM Tris-HCl, pH 8.0,
85 mM KCl, 0.5% NP40, 16protease inhibitor cocktail (Roche))
and incubated on ice for 10 min. After centrifugation (5 min,
5000 rpm at 4uC), the pellet was resuspended in 1.8 ml of RIPA
buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA, pH 8.0,
140 mM NaCl, 0.1% SDS, 0.1% sodium deoxycholate, 1%
Triton X-100, 1 mM PMSF, 16 protease inhibitor cocktail),
sonicated and centrifuged at 13000 rpm for 10 min at 4uCt o
remove cell debris. Aliquots of the supernatant (cellular and viral
chromatin) were stored at 280uC.
For preparation of input DNA 20ul of chromatin was incubated
in 100ul of TE buffer containing 50ug/ul RNase A for 30 min at
37uC. The samples were then adjusted to contain 0.5% SDS and
0.5mg/ml Proteinase K (Invitrogen) and incubated for 1 hr at
37uC. Formaldehyde crosslinks were reversed by adding sodium
chloride (final concentration 300 mM) to the samples and
incubated overnight at 65uC. DNA was extracted first by one
volume of phenol/chloroform/isoamyl alcohol (25:24:1) saturated
with 10 mM Tris, pH8.0 and 1 mM EDTA and then purified
once by one volume of chloroform. DNA was precipitated by cold
absolute ethanol, 10% (v/v) of 3 M sodium acetate, pH 5.2 and
1ul of 15 mg/ml Glycogen Blue (Ambion) at 280uC at least for
1 hr following by wash with 70% ethanol. Finally the input DNA
was dried at RT and resuspended in 20ul of water.
For ChIPs chromatin containing 10ug of DNA was first diluted
in 500ul of RIPA buffer and precleared by Sepharose A beads.
Immunoprecipitation was carried out with 1–2ug of antibodies
overnight at 4uC. Next day to pull down the DNA/protein
complexes, Protein-A/G agarose was added for 4 hr. Immuno-
precipitation was washed sequentially with RIPA buffer once
briefly and once for 10 min followed by washing with LiCl buffer
(10 mM Tris-HCl, pH 8.0, 1mM EDTA, pH 8.0, 250 mM LiCl,
0.5% NP-40, 0.5% sodium deoxycholate) once for 10 min and
with TE buffer two times for 10 min. The DNA/protein-Protein
A/G agarose complex was resuspended in 100ul of TE buffer
containing 50ug/ul RNase A and incubated for 30 min at 37uC.
The Proteinase K treatment, crosslink reversal and DNA
purification was done exactly as it was described at the preparation
of input DNA. Both input and ChIP DNAs were measured by
qPCR. Based on the standard curves for each primer pairs the
enrichment of proteins and histone modifications on specific
genomic regions were calculated as percentage of the immuno-
precipitated DNA compared to input DNA. Each data points in
ChIP figures were averages of at least three independent ChIPs
using three independent chromatins.
Sequential ChIP (seqChIP) was performed as follows. ChIPs
were carried out as described above except that after the first ChIP
(ChIP I.) the immunoprecipitated DNA/protein complexes were
eluted from the Protein A/G agarose by 100ul of Elution buffer
(50 mM Tris-HCl, pH 7.5, 10 mM EDTA, pH 8.0, 1% SDS) by
heating for 10–15 min at 65uC. 10% of the elution was saved for
qPCR while the rest was diluted with RIPA buffer up to 1 ml and
the second immunoprecipitation (ChIP II.) was performed exactly
as described above for ChIP. The second ChIP was also measured
by qPCR and the enrichment of the histone modifications on
specific genomic regions was calculated as percentage of the
immunoprecipitated DNA compared to the total amount of DNA
eluted after the first ChIP. Each ChIP values were averages of
three independent ChIPs using three independent chromatins.
Quantitative real-time PCR (qPCR)
qPCR was performed using iQ SYBR Green Supermix (Bio-
Rad) and CFX96 real-time PCR machine (Bio-Rad). PCR
program was as follows: after an initial preincubation step at
95uC for 3 min, there were 40 cycles, each consisting of 95uC for
10sec, 64.5 or 59uC depending on the primers (Table S1) for
20 sec and 72uC for 20sec. The last amplification cycle was
followed by a melt curve analysis to make sure about the specificity
of the qPCR amplification. As for ChIP 0.45ul of ChIP DNA and
4.5ng of input DNA were measured in qPCR. Quantification of
the amplifications in qPCR was based on standard curves for each
primer pairs. Sequences of the primers used in ChIP experiments
can be found in Table S1.
RNA isolation and RT-PCR
Total cellular RNA was extracted with Tri reagent (Sigma)
according to the manufacturer’s instructions. 1ug of total RNA
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cDNA Synthesis kit (Bio-Rad) and the cDNA was measured by
either conventional PCR or qPCR. The relative quantification of
gene expression was calculated with the ddCt method, where actin
mRNA was used for normalization. RT-PCR graphs were made
based on the average of at least two independent experiments.
Lentiviral shRNA knockdown
The shRNA constructs were prepared by using the pLKO.1
lentiviral vector. The target sequences are listed in Table S1.
Supernatants from 293T cells transfected by the shRNA and
packaging vectors were collected 60 hours post transfection
followed by concentration of the virus (24000 rpm, 1.5 hr, 4uC)
and used for spinning infections (1800 rpm, 45 min) of one million
of BCBL-1 cells in the presence of 10 ug/ml polybrene. 5 days
post infection cells were harvested for western blot and RT-qPCR
analysis.
KSHV tiling microarray and ChIP-on-chip
The 15 bp-tiling KSHV microarray contains both KSHV and
human probes and was manufactured by Agilent Technologies.
The probes were spotted on 8615K array format. The majority of
the oligonucleotides are overlapping 60-mer probes covering the
entire KSHV genome (U75698 and U75699 at GenBank). In
addition, probes specific for the gene regulatory regions of 71
human genes were also included in the microarray. The human
probes are derived from the Agilent Human CoC 26244k
microarray design. For ChIP-on-chip 30 ug of chromatin and
5–6 ug of antibodies were used per ChIP. The ChIP and DNA
purification was performed exactly as described above. ChIP DNA
was amplified by Complete Whole Genome Amplification
(WGA2) kit (Sigma-Aldrich) and purified with QIAquick PCR
Purification kit (Qiagen) according to the instructions of the
manufacturers. Labeling, hybridisation and scanning of the
microarrays were done at the Functional Genomics Core,
Microarray Service at City of Hope (California). Probe signals
were extracted using the Agilent Feature Extraction software
(version 10.5.1.1). Each ChIP-on-chip experiment was performed
two times and the average of the biological replicates is shown in
Figures 1, 2, 4A, S5, S6, S8. The biological replicates can be found
in Figures S3, S4, S5.
Normalization, visualization and cluster analysis of the
ChIP-on-chip data
Log2 (Cy5/Cy3) of the mean signals of the probes were
calculated, and imported into R software (version 2.9.0) (http://
www.r-project.org). Using the Bioconductor package ‘‘aroma.
light,’’ lowess normalization as implemented by the function
‘‘normalizeLoess,’’ was used to correct for die bias. The log2 ratios
for samples at 0hpi and 12hpi were scaled to have the same
median absolute deviation (MAD) using the function ‘‘normal-
izeBetweenArrays,’’ from the ‘‘limma’’ Bioconductor package
[76,77,78,79].
To visualize enrichment across the KSHV genome, the
normalized log2 ratios for each overlapping probe were averaged
and a score was assigned to each base pair (bp). A moving average
was calculated across the genome by sliding a 150-bp window
stepwise by 1 bp unidirectionally. When calculating the moving
average, the window is shifted past regions where there are missing
probes so that regions with missing probes do not have any weight.
Regions where no probes exist were assigned an enrichment value
of ‘‘0.’’ Log2 ratios were converted to linear scale, and tracks in
BED format were created for each sample. Tracks were then
imported into Genetrix software (Epicenter Software) for visual-
ization.
For the KSHV promoter array analysis promoter regions were
defined as 1000 bp upstream and downstream of the translational
start sites (TSS) of each viral gene. The coordinates of ORFs are
listed in Table S2 [80]. Normalized log2 ratios were calculated as
described above. Log2 ratios were averaged for each 50 bp
nonoverlapping window upstream and downstream of the TSS
within the promoter for each gene. The TSS was assigned a single
score. The resulting matrix was applied to perform hierarchical
clustering with Cluster 3.0 (http://bonsai.ims.u-tokyo.ac.jp/
,mdehoon/software/cluster/software.htm). The results of clus-
tering were then imported into Java TreeView for visualization
(version 1.1.4r2) [81].
While the 0 hpi-ChIPs were compared to the 0 hpi-DNA inputs
in ChIP-on-chips the 12 hpi-ChIP-on-chips were analysed in two
different ways. (1) 12 hpi-ChIPs were compared to 0 hpi-ChIPs
(Figure S3, S4, S5, S6, S7, S8, S10) or (2) the 12 hpi-ChIP/input
ratio was calculated by multiplying the 0 hpi-ChIP/input ratios by
the 12 hpi-ChIP/0 hpi-ChIP ratios (Figure 1 and 2).
Supporting Information
Figure S1 RTA-mediated reactivation of KSHV. (A)
TRExBCBL1-RTA cells were treated by 1 ug/ml of doxycycline
for 6, 12 and 24 hours and subject to immunoblot analysis with
the indicated antibodies. myc/His-Rta was detected by anti-myc
antibody. Actin was used to monitor protein amounts in the cell
lysates. (B) An aliquot of cells used in (A) was used for purification
of total RNA to measure the indicated viral mRNAs. (C) Using
the same number of cells, the copy number of KSHV genome in
Dox-induced (6, 12, 24 hpi) TRExBCBL1-RTA cells relative to
that in non-induced (0 hpi) cells were determined by qPCR using
primers specific for the indicated genomic regions. The amount of
viral DNA was normalized for the cellular DNA input.
Found at: doi:10.1371/journal.ppat.1001013.s001 (0.35 MB TIF)
Figure S2 Dissociation of histone H3 from the replicating
KSHV genome. (A) The schematic map shows the KSHV
genome and arrows indicate the KSHV genomic regions tested in
ChIPs. RTA and LANA promoters are shown in more details. 1 to
16 represents genomic regions spanning the RTA promoter and
the intron of RTA (+0.8 kb) relative to the translational start site of
RTA. CBF1-binding sites are highlighted in blue. (B) Non-
induced and Dox-induced TRExBCBL1-RTA cells were used to
perform ChIPs for hisone H3 on different viral gene promoters or
(C) on cellular promoters. (D) Non-induced and Dox-induced
TRExBCBL1-RTA cells were tested in immunoblot for histone
H3 and indicated histone modifications.
Found at: doi:10.1371/journal.ppat.1001013.s002 (0.59 MB TIF)
Figure S3 Genome-wide mapping of histone modifications on
the KSHV genome during latency and reactivation. It shows one
of the biological replicates of the ChIP-on-chip experiments
(Chromatin A). Details are described in Figure 1 and S7. (A) ChIP-
on-chip for histone H3. (B) Histone modifications on the KSHV
genome during latency. (C) Changes of histone modification on
the KSHV genome upon lytic reactivation.
Found at: doi:10.1371/journal.ppat.1001013.s003 (0.88 MB TIF)
Figure S4 Genome-wide mapping of histone modifications on
the KSHV genome during latency and reactivation. It shows one
of the biological replicates of the ChIP-on-chip experiments
(Chromatin B). Details are described in Figure 1 and S7. (A) ChIP-
on-chip for histone H3. (B) Histone modifications on the KSHV
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the KSHV genome upon lytic reactivation.
Found at: doi:10.1371/journal.ppat.1001013.s004 (0.88 MB TIF)
Figure S5 Normalization of the ChIP-on-chip data by histone
H3 at 0 hpi. The ChIP-on-chip experiments were performed as
described in Figure 1. The 0 hpi-histone modification ChIP-on-
chip data were derived from two independent chromatins
(Chromatin A and B), which were divided by the relevant 0 hpi-
H3 ChIP-on-chip dataset (the upper and middle panels). The
average of the H3-normalized 0 hpi-ChIP-on-chip dataset is
shown in the lower panel.
Found at: doi:10.1371/journal.ppat.1001013.s005 (0.67 MB TIF)
Figure S6 Comparison of the hierarchical clustering of histone
modifications associated with the regulatory regions of viral genes
with and without H3 normalization. The clustering was performed
as described in Figure 2. (A) The 0 hpi-ChIP-on-chip dataset used
in the hierarchical clustering without normalization for histone
H3. The clustering was taken from Figure 2A. (B) The 0 hpi-
ChIP-on-chip dataset used in the hierarchical clustering was
normalized for changes in histone H3.
Found at: doi:10.1371/journal.ppat.1001013.s006 (2.96 MB TIF)
Figure S7 Genome-wide mapping of histone modifications on
the KSHV genome during latency and reactivation. Each ChIP-
on-chip experiment is an average of two biological replicates. (A)
Histone H3 ChIP-on-chip is the same as in Figure 1. (B) Histone
modification ChIP-on-chips were performed using non-induced
TRExBCBL1-Rta cells. (C) ChIP-on-chips were performed with
TRExBCBL1-Rta cells induced by doxycycline for 12 hours.
Changes of the distribution of histone modifications during
reactivation (12 hpi) are shown as the normalized Cy5/Cy3 ratio
of 12 hpi-ChIP DNA over 0 hpi-ChIP DNA. Red line indicates
that the Cy5 (ChIP at 12 hpi)/Cy3 (ChIP at 0 hpi) ratio equals one
showing that there is no change in the level of histone
modifications between 0hpi and 12hpi. Numbers in the left upper
corners show the maximum values of Cy5/Cy3. Missing probes in
specific genomic regions are shown below the genome scale (**).
The alternating dark and light blue squares atop display the viral
ORFs where the white triangle indicates ORFs that are expressed
from the reverse DNA strand. The hpi stands for hours post-
induction.
Found at: doi:10.1371/journal.ppat.1001013.s007 (0.85 MB TIF)
Figure S8 Hierarchical clustering of histone modifications
associated with the regulatory regions of viral genes. Based on
their expression patterns the viral genes were grouped as latent,
IE, E and L genes and hierarchical clustering was performed
within the groups. Details are described in Figure 2. Panel A is
identical with Figure 2A while panel B shows 12 hpi-ChIP/0 hpi-
ChIP based on Figure S7.
Found at: doi:10.1371/journal.ppat.1001013.s008 (2.64 MB TIF)
Figure S9 IE genes are repressed during latency but rapidly
induced upon reactivation. Total RNAs were purified from non-
induced (0 hpi) and induced (6, 12, 24 hpi) TRExBCBL1-RTA
cells followed by RT-PCR using specific primers for the indicated
IE transcripts. RT+: cDNA synthesis was performed with reverse
transcriptase, RT2: cDNA synthesis reaction did not include
reverse transcriptase.
Found at: doi:10.1371/journal.ppat.1001013.s009 (0.25 MB TIF)
Figure S10 Colocalization of EZH2 and H3K27me3 on the
regulatory region of KSHV genes. Hierarchical clustering of
EZH2 and H3K27me3 associated with the regulatory region of
KSHV genes is performed as described in Figure 2.
Found at: doi:10.1371/journal.ppat.1001013.s010 (1.34 MB TIF)
Figure S11 Binding of CBF1 to the RTA promoter is essential
for RTA-mediated activation of its own promoter. (A) Schematic
diagrams of deletion mutants of the RTA promoter fused to the
luciferase reporter gene. The size of the tested promoter regions
relative to the translational start site of RTA is indicated on the
left. (B) The deletion mutants were transfected into 293A cells in
the absence or presence of RTA and assayed for luciferase activity.
Data represent the average of three independent experiments. (C)
Nuclear extract of BCBL1 was subject to DNA affinity purification
with DNA fragments derived from the RTA promoter region.
Fragment A includes the 3 CBF1 binding sites at 21.4 kb relative
to the translational start site of RTA. Fragment B is derived from
the adjacent promoter region of Fragment A that does not contain
any CBF1 binding sites. Immunoblot was performed with an anti-
CBF-1 specific antibody.
Found at: doi:10.1371/journal.ppat.1001013.s011 (0.13 MB TIF)
Figure S12 Overexpression of histone demethylases in Vero
cells. (A) Overexpressed HMTs were detected by immunoblotting
with HA-, JMJD2A- and JMJD3-specific antibodies. (B and C)
HA-tagged JMJD2A, JMJD3, UTX and UTXm were transfected
into Vero cells, which were subject to immunofluorescent analysis
at 3 days post-transfection. The expression of enzymatically active
JMJD2A suppressed the steady-state level of H3K9me3, whereas
JMJD3 and UTX decreased H3K27me3 in transfected cells.
Found at: doi:10.1371/journal.ppat.1001013.s012 (1.27 MB TIF)
Figure S13 Induction of apoptosis is not sufficient to induce
KSHV reactivation. (A) JSC-1 cells were treated with 5 uM
DZNep for 1, 2 and 3 days (dpt) and then harvested for
immunoblot analysis with an anti-PARP antibody. (B) JSC-1 cells
were treated with different concentrations of DZNep for 3 days
and then subject to immunoblot analysis with the indicated
antibodies. (C) JSC-1 cells were treated with 200 nM of
staurosporine (STS) for 1, 2 and 3 days followed by immunoblot
analysis for the indicated cellular proteins and histone modifica-
tions (H3K27me3, H3K9me3). (D) A portion of control and 3dpt
JSC-1cells used in (C) was used for RNA purification and the levels
of the indicated KSHV mRNA were measured by RT-qPCR.
Found at: doi:10.1371/journal.ppat.1001013.s013 (0.55 MB TIF)
Table S1 Primer sequences
Found at: doi:10.1371/journal.ppat.1001013.s014 (0.06 MB
DOC)
Table S2 Genomic coordinates of the open reading frames of
KSHV. IE=immediate early, E=early, L=late. Start codon
coordinates indicate the first nucleotide of the KSHV genes and
the stop codon coordinates indicate the last nucleotide in the stop
codon of the KSHV genes. Coordinates are based on U75698.1 at
GenBank.
Found at: doi:10.1371/journal.ppat.1001013.s015 (0.05 MB
DOC)
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